Key Highlights
- Lakewood-Amedex Biotherapeutics Inc. (NASDAQ:LABT) rose 290.33% on Volume near 45 times normal, while Antelope rose 78.63% on volume near 47 times normal, the heaviest turnover relative to history in this group.
- Zeta Network Group (NASDAQ:ZNB) rose 73.7% on an unconfirmed AI infrastructure theme, with cash of about USD 44,000 and a Going Concern warning in its latest annual report.
- Elong Power Holding Limited (NASDAQ:ELPW) rose 44.31% on a RMB 2 billion framework deal, against a Market Value near USD 3.38 million and an unnamed counterparty.
- Baird Medical Investment Holdings Limited (NASDAQ:BDMD) rose 20.26% to USD 0.1312 on about 108.64 million shares, a day after a Nasdaq bid price notice and a statement that it knew of no undisclosed development.
Lakewood-Amedex Biotherapeutics Inc. (NASDAQ:LABT): A Float of About 1.4 Million Shares
The sharpest spike belongs to Lakewood-Amedex Biotherapeutics Inc. (NASDAQ:LABT), quoted at USD 0.7471 in trading on November 5, 2026, per published market data, up 290.33% from about USD 0.19, on about 351 million shares and relative volume near 45 times normal. A float of roughly 1.4 million shares in published coverage means a handful of buyers can overwhelm sellers. The visible catalyst is a release at 8:02 a.m. ET that the company completed the Redemption of all 127,097 Series C Convertible Preferred Shares for USD 1,270,970 in cash, under an agreement dated November 2, 2026. That removes a source of conversion shares, a benefit for a low-priced stock, but the same release warns that runway may fall. Published market data cites a market value well below USD 2 million. In that setting spreads can be wide, a small number of trades can move the price and quoted moves can reverse sharply, as the intraday range has already shown.
Zeta Network Group (NASDAQ:ZNB): Going Concern Doubt Behind a 73.7% Jump
At Zeta Network Group (NASDAQ:ZNB), the 73.7% rise to USD 1.0804 on about 61.08 million shares and relative volume of about 17 times normal was linked in published coverage to an AI infrastructure expansion, which the company has not detailed and which stays unconfirmed. The latest annual report, a Form 20-F for the year to June 30, 2026, shows Revenue of about USD 28.4 million, up 225%, but a net loss of about USD 157.5 million including a USD 114.0 million Impairment on SolvBTC, a bitcoin-linked token. Cash was only about USD 44,000 and management states substantial doubt about continuing as a going concern. Reverse splits of 100-for-1 on March 12, 2026 and 8-for-1 on July 27, 2026 were done to address the Nasdaq minimum bid rule, and convertible notes of up to USD 10 million with warrants add dilution. A reverse split merges shares into fewer, higher-priced ones, and the price often drifts lower afterward. With a market value near USD 5.4 million, quoted gains can fade.
Elong Power Holding Limited (NASDAQ:ELPW): A USD 300 Million Headline and a USD 3.38 Million Market Value
The 44.31% gain at Elong Power Holding Limited (NASDAQ:ELPW), to USD 3.62 on about 46.71 million shares, followed a November 5, 2026 announcement of a three-year cooperation agreement for no less than RMB 2 billion, about USD 300 million, of energy storage equipment with an unnamed grid-side developer. A first purchase contract of no less than RMB 300 million, about USD 45 million, is scheduled for January 2027. The release gave no delivery schedule, capacity or payment terms, and a framework sets a ceiling, not guaranteed orders. Published market data puts the market value near USD 3.38 million, a fraction of the headline. The company's first-half revenue was USD 2.9 million at a gross Margin near 0.3%, it effected a 1-for-45 reverse split on August 10, 2026, and it has raised money repeatedly through offerings in 2026 per published coverage. In a small float a limited number of trades can move the price, and quoted moves can reverse when the order flow slows.
Antelope Enterprise Holdings Limited (NASDAQ:AEHL): The Highest Relative Volume in the Group
At Antelope Enterprise Holdings Limited (NASDAQ:AEHL), the 78.63% gain to USD 11.20 came on relative volume near 47 times normal, the highest here, yet no new company announcement for November 5, 2026 was located. Published coverage put the November 4 close near USD 6.27. The share count has been reshaped by reverse splits of 1-for-6 on March 4, 2026 and 1-for-16 on August 7, 2026, leaving about 1,309,197 shares before later issuance, so very few shares are available to trade. An at-the-market agreement signed October 1, 2026 allows up to USD 100 million of Class A shares to be sold into the market over time, which adds Supply and dilutes holders. Convertible notes convert at 80% of the lowest daily volume-weighted average price over three trading days, subject to a Nasdaq 19.99% cap, which gives holders an incentive to sell after converting. Published coverage describes a spike to about USD 30.60 on October 14, 2026 that closed near USD 11.49. A thin float means quoted moves can reverse.
Baird Medical Investment Holdings Limited (NASDAQ:BDMD): A Bid Price Warning Meets 108 Million Shares of Volume
The 20.26% rise at Baird Medical Investment Holdings Limited (NASDAQ:BDMD), to USD 0.1312, is the smallest in the group but came on about 108.64 million shares, roughly five times normal volume. On November 4, 2026 the company announced a Nasdaq letter dated November 2, 2026 under Listing Rule 5550(a)(2), after its bid stayed below USD 1.00 for 30 consecutive Business days. It has 180 calendar days, until May 3, 2027, to regain compliance by closing at or above USD 1.00 for ten consecutive business days. A separate statement the same day said management knew of no undisclosed reason for the share price decline. The notice did not mention a reverse split and none is confirmed. At about USD 0.13 and a market value near USD 4.2 million, a recovery without a split would need a gain of more than sevenfold, simple arithmetic on two published numbers. Heavy turnover at this price signals speculation rather than new fundamentals, and quoted moves can reverse.
Where Things Stand
These spikes reflect speculation and small floats more than improved fundamentals, and the balance of evidence says traders should treat each move as fragile. Lakewood-Amedex Biotherapeutics Inc. (NASDAQ:LABT) has a real announcement but a tiny float. Elong Power Holding Limited (NASDAQ:ELPW) has a framework deal with an unnamed partner. Zeta Network Group (NASDAQ:ZNB) has unconfirmed coverage and a going concern warning. Antelope Enterprise Holdings Limited (NASDAQ:AEHL) had no located trigger. Baird Medical faces a listing deadline. Volume that runs many times normal in tiny floats often signals turnover rather than conviction, and nothing here implies the gains will continue. The next markers are financing filings, Nasdaq correspondence, the January 2027 Elong contract and any compliance plan at Baird Medical Investment Holdings Limited (NASDAQ:BDMD).





_11_20_2026_12_38_15_908731.jpg)
Please wait processing your request...